Loading…
Community Health Center Drug Pricing Protection Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 10,940 other HR bills in the 119th — cohort avg 30d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (10)
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2026 · third_quarter · Health Issues
- H.R. 1539, Medical Device Electronic Labeling Act, regarding all provisions - H.R. 929/S. 266, the Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, regarding all provisions - H.R. 946 ORPHAN Cures Act, regarding all provisions - S.864, HELP Copays Act, regarding all provisions - H.R. 2214, Delinking Revenue from Unfair Gouging (DRUG) Act, regarding all provisions - H.R. 1492/S. 832, Ensuring Pathways to Innovative Cures (EPIC) Act, regarding all provisions - S. 1954/ H.R. 5526 Biosimilar Red Tape Elimination Act, regarding all provisions - H.R.2527, Early Detection of Vision Impairments for Children Act of 2025, regarding all provisions - PL117-169 The Inflation Reduction Act, regarding all provisions related to drug pricing and implementation - H.R.5343/S. 1717, the Ensuring Patient Access to Critical Breakthrough Products Act of 2025, regarding all provisions - H.R.4282, Contact Lens Prescription Verification Modernization Act, regarding all provisions - H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act, regarding all provisions - S.1399 / H.R. 6197, the Health Tech Investment Act, regarding all provisions - H.R. 3521, the Clinical Trial Modernization Act, regarding all provisions - H.R. 3006 / S.1776, the Medicare Beneficiary Co-Pay Fairness Act, regarding all provisions - H.R. 3514, the Improving Seniors Timely Access to Care Act of 2025, regarding all provisions - H.R. 6549, the VA Contracting and Procurement Act, regarding all provisions - H.R. 5509 / S. 2903, Safe Step Act, regarding all provisions - H.R. 5256, 340B ACCESS Act, regarding all provisions - H.R. 7391, Community Health Center Drug Pricing Protection Act, regarding all provisions - H.R. 3953 / S. 1874 Title VIII Nursing Workforce Reauthorization Act, regarding all provisions Issues related to - direct to consumer advertising - clinical trial modernization - biosimilars - cardiovascular health - 340B and 340B Rebate Pilot - Heart Recovery Awareness Day & H.Res. 1301, designating February 20th Heart Recovery Awareness Day - MFN - Foreign Reference Pricing - CMS Outpatient Prospective Payment System rule - peripheral artery disease (PAD) - PBM and Insurer Reforms
Client expense: $2,220,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2026 · third_quarter · Health Issues
Discretionary funding for the Health Center Program, the National Health Service Corps, and the Teaching Health Centers Graduate Medical Education Program that is funded via the Appropriations measure covering the Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations for FY 2027 in both the House and the Senate. The Community Health Center Fund reauthorization; this "extender" must be reauthorized by December 31, 2026. Lobbying related to ACH's proposed CHC Value and Innovation Fund; H.R.1 One Big Beautiful Bill Act implementation, specifically state-based operations to implement the Rural Health Transformation Program and Community Engagement Requirements Issues related to CMS Interim Final Rule implementing Community Engagement Requirements & Notice of Proposed Rulemaking for Medicaid Managed Care State Directed Payments and Medicaid Fee-for-Service Targeted Medicaid Practitioner Payments. H.R. 10398, the Community Health Center Reforms Enabling Better Access for Seniors and Elders (CHC REBASE) Act. Medicare/Duals issues including Medicare PPS payments, the PACE program, and telehealth flexibilities in the Medicare program. 340B Drug Pricing Program legislation, including HR 10770, the 340B Rebate Model Delay Act; HR 5244, the SUSTAIN 340B Act; HR 9599, the SECURE 340B Act; the 340B Patients Act (S 2372 & HR 4581); the Community Health Center Drug Pricing Protection Act (HR 7391). Comments and legislative efforts to block 340B Rebate Model Pilot Program efforts and manufacturers efforts to compel claims data Issues and legislation related to the primary care workforce, including the Developing the Community Health Workforce Act (HR8629), the Health Workforce Innovation Act (HR935), H-1Bs for Physicians and the Healthcare Workforce Act (HR7961), the Community TEAMS Act of 2025 (HR3885), funding for Title 7 & Title 8 workforce programs and activities related to a new workforce coalition, The Alliance to Strengthen Americas Health Workforce for the Underserved Issues related to CMMI models and health center participation in value-based care payment arrangements, including MAHA Elevate, ACCESS, and LEAD Issues related to the Health Center Community Transformation Hub Act (Has not been reintroduced in 119th Congress) Issues related to the Trump Administrations stance on community health centers and primary care workforce funding, including the Make America Healthy Again agenda (nutrition and chronic disease management). Legislation being developed by Senator Warnock to establish an HRSA grant program to help Section 330 grantees maintain and modernize mobile units.
Client expense: $65,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE, White House Office
2026 · third_quarter · Health Issues
NACHC lobbies for Teaching Health Center Graduate Medical Education; Nurse Corps; National Health Service Corps; 340B Drug Discount Program; Community Health Center Program; Behavioral Health; Telehealth; and Nutrition policies. This includes the Community Health Center Drug Pricing Protection Act (H.R.7391), SUSTAIN 340B Act (S. 5244), and SECURE 340B Act (H.R. 9599).
Client expense: $194,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE, White House Office
2026 · third_quarter · Pharmacy
Prescription drug pricing policy. H.R.1492 - Ensuring Pathways to Innovation Cures (EPIC) Act. ORPHAN Cures Act. MINI Act. H.R.4299 - Protecting Patient Access to Cancer and Complex Therapies Act. H.R.7391 - Community Health Center Drug Pricing Protection Act. H.R.5509 - Safe Step Act. Clinical Trial Modernization Act. Essential medicines/Buy American. Issues related to the 340B Drug Pricing Program. International Reference Pricing/Most Favored Nation.
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Health Issues
Monitoring healthcare legislation. Education regarding market based solutions to bring down the cost of drug prices. Education regarding the dangers of global counterfeit medications. Education regard the International Pricing Index (IPI) Model, which would import single-payer government run price controls that limit innovation and patient access to life saving therapies. Support for PBM reform. HR 2214 -- "DRUG Act" HR 1492 -- "To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program." S.832 - "EPIC Act of 2025." Education regarding the Most Favored Nation Executive Order. Support the 340B CMS pilot program. HR 7391 "Community Health Center Drug Pricing Protection Act."
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2026 · third_quarter · Health Issues
issues pertaining to 340B rebate pilot program, support of Community Health Center Drug Pricing Protection Act (HR 7391)
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Health Issues
issues pertaining to 340B rebate pilot program, support of Community Health Center Drug Pricing Protection Act (HR 7391)
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Health Issues
Issues related to the Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations for FY 2027, including written testimony to the U.S. House Appropriations Committee and U.S. Senate Appropriations Committee subcommittees on Labor, Health and Human Services, Education, and Related Agencies on CHC Funding H.R.1 One Big Beautiful Bill Act implementation, specifically state-based operations to implement the Rural Health Transformation Program Issues related to CMS Interim Final Rule implementing Community Engagement Requirements & Notice of Proposed Rulemaking for Medicaid Managed Care State Directed Payments and Medicaid Fee-for-Service Targeted Medicaid Practitioner Payments 340B Drug Pricing Program legislation, including the SUSTAIN Act, 340B Patients Act (HR 4581), the Community Health Center Drug Pricing Protection Act (HR 7391), and proposed 340C legislation Comments and legislative efforts to block 340B Rebate Model Pilot Program efforts and manufacturers efforts to compel claims data Statement submitted to the House Committee on Budgets hearing, Reverse the Curse: Skyrocketing Health Care Costs and Americas Fiscal Future Issues and legislation related to the primary care workforce, including introduction of the Developing the Community Health Workforce Act (HR8629), the Health Workforce Innovation Act (HR935), H-1Bs for Physicians and the Healthcare Workforce Act (HR7961), the Community TEAMS Act of 2025 (HR3885), funding for Title 7 & Title 8 workforce programs and activities related to a new workforce coalition, The Alliance to Strengthen Americas Health Workforce for the Underserved Issues related to CMMI models and health center participation in value-based care payment arrangements, including MAHA Elevate, ACCESS, and LEAD Issues related to the Health Center Community Transformation Hub Act (Has not been reintroduced in 119th Congress) Issues related to the Trump Administrations stance on community health centers and primary care workforce funding, including the Make America Healthy Again agenda (nutrition and chronic disease management) and the Presidents proposed budget
2026 · second_quarter · Health Issues
H.R.1492, Ensuring Pathways to Innovation Cures (EPIC) Act Implementation of Inflation Reduction Act of 2022 ORPHAN Cures Act MINI Act H.R.4299, the Protecting Patient Access to Cancer and Complex Therapies Act of 2025 H.R.7391, CHC Drug Pricing Protection Act H.R.5509, Safe Step Act Issues related to biosimilars reimbursement issues Clinical Trial Modernization Act Essential medicines/Buy American regarding all bio-pharmaceutical provisions
Client expense: $3,160,000 · Firm income: Not reported
2026 · second_quarter · Health Issues
NACHC lobbies for Teaching Health Center Graduate Medical Education; Nurse Corps; National Health Service Corps; 340B Drug Discount Program; Community Health Center Program; Behavioral Health; Telehealth; and Nutrition policies. This includes the Community Health Center Drug Pricing Protection Act (H.R.7391).
Client expense: $213,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE, White House Office
2026 · second_quarter · Health Issues
- H.R. 1539, Medical Device Electronic Labeling Act, regarding all provisions - H.R. 929/S. 266, the Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, regarding all provisions - H.R. 946 ORPHAN Cures Act, regarding all provisions - S.864, HELP Copays Act, regarding all provisions - H.R. 2214, Delinking Revenue from Unfair Gouging (DRUG) Act, regarding all provisions - H.R. 1492/S. 832, Ensuring Pathways to Innovative Cures (EPIC) Act - S. 1954/ H.R. 5526 Biosimilar Red Tape Elimination Act, regarding all provisions - H.R.2527, Early Detection of Vision Impairments for Children Act of 2025, regarding all provisions - PL117-169 The Inflation Reduction Act, regarding all provisions related to drug pricing and implementation - H.R.5343/S. 1717, the Ensuring Patient Access to Critical Breakthrough Products Act of 2025, regarding all provisions - H.R.4282, Contact Lens Prescription Verification Modernization Act, regarding all provisions - H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act, regarding all provisions - S.1399 / H.R. 6197, the Health Tech Investment Act, regarding all provisions - H.R. 3521, the Clinical Trial Modernization Act, regarding all provisions - H.R. 3006 / S.1776, the Medicare Beneficiary Co-Pay Fairness Act, regarding all provisions - H.R. 3514, the Improving Seniors Timely Access to Care Act of 2025, regarding all provisions - H.R. 6549, the VA Contracting and Procurement Act, regarding all provisions - H.R. 5509 / S. 2903, Safe Step Act, regarding all provisions - H.R. 5256, 340B ACCESS Act, regarding all provisions - H.R. 7391, Community Health Center Drug Pricing Protection Act, regarding all provisions Issues related to - direct to consumer advertising - clinical trial modernization - biosimilars - cardiovascular health - 340B and 340B Rebate Pilot - Heart Recovery Awareness Day & H.Res. 1301, designating February 20th Heart Recovery Awareness Day - obesity treatments - MFN - Foreign Reference Pricing - CMS Outpatient Prospective Payment System rule - peripheral artery disease (PAD) - PBM and Insurer Reforms
2026 · second_quarter · Medicare/Medicaid
H.R. 7391 - Community Health Center Drug Pricing Protection Act Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Vaccine Access and Coverage 340B Program Reform PBM Reform Direct-to-Patient Prescription Drug Purchase Platforms and Insurance Coverage Step Therapy Practices Drug Pricing Medicare/Medicaid Issues
Client expense: $1,880,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Health Issues
Vaccine Coverage and Coverage Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Codification and Sec. 301 trade investigations FDA User Fee Agreements: 2027 PDUFA Cycle H.R. 7837 - Most Favored Patient Act of 2026 H.R. 7391 - Community Health Center Drug Pricing Protection Act 340B Program Reform Inflation Reduction Act (IRA) H.R. 8646 - Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriates Act, 2027 H.R. 9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriation Act, 2027 H.R. 5178 - Sickle Cell Disease Comprehensive Care Act H.R. 5526 - Biosimilars Red Tape Elimination Act H.R. 4930 - To Expand the Sharing of Information with Respect to Suspected Violations of Intellectual Property Rights in Trade H.R. 4299 - Protecting Patient Access to Cancer and Complex Therapies Act: IRA reforms Prior Authorization Step Therapy Practices FDA Modernization and Reforms Drug Pricing PBM Reform Direct-to-Patient Prescription Drug Purchase Platforms and Insurance Coverage
Client expense: $1,880,000 · Firm income: Not reported
2026 · second_quarter · Pharmacy
The SECURE 340B Act (H.R. 9599); The Tax-Exempt Hospital Transparency Act (H.R.9504); 340B PATIENTS Act (H.R. 4581/S.2372); Community Health Center Drug Pricing Protection Act (H.R. 7391); 2027 OPPS Proposed Rule; Information Collection Request Title: 340B Rebate Model Pilot Program Application, Implementation, and Evaluation, OMB Number 0906-NEW; Manufacturer Demand for Access to in-House Pharmacy Claims Data; Lilly 340B Drug Pricing Denial; HRSA Rebate Model Pilot pending regulation; Pending Senate "Gang of Six" draft 340B legislation; FY27 Appropriations legislation; Pending introduction of updated and expanded Community Health Center Drug Pricing Protection Act.
Client expense: $240,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
2026 · second_quarter · Health Issues
Monitoring healthcare legislation. Education regarding market based solutions to bring down the cost of drug prices. Education regarding the dangers of global counterfeit medications. Education regard the International Pricing Index (IPI) Model, which would import single-payer government run price controls that limit innovation and patient access to life saving therapies. Support for PBM reform. HR 2214 -- "DRUG Act" HR 1492 -- "To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program." S.832 - "EPIC Act of 2025." Education regarding the Most Favored Nation Executive Order. Support the 340B CMS pilot program. HR 7391 "Community Health Center Drug Pricing Protection Act."
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2026 · second_quarter · Health Issues
S. 355: FDA Modernization Act 3.0 S. 652: Protecting Patients from Deceptive Drug Ads Act S. 832: Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025 S. 864: HELP Copays Act S. 1414: Expedited Access to Biosimilars Act S. 1954: Biosimilar Red Tape Elimination Act S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) S. 2658: Medication Affordability and Patent Integrity Act S. 3014: Ensuring Timely Access to Generics Act of 2025 S. 3345: PBM Price Transparency and Accountability Act S. 3788: CLEAR LABELS Act H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) H.R. 946: ORPHAN Cures Act H.R. 1262: Mikaela Naylon Give Kids a Chance Act H.R. 1492: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program H.R. 2214: DRUG Act H.R. 3521: Clinical Trial Modernization Act H.R. 4317: PBM Reform Act of 2025 H.R. 5256: 340B ACCESS Act HR 5509, Safe Step Act, Provisions related step therapy protocols H.R. 6423: HELP Copays Act H.R. 6610: Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act] H.R. 7837: Most Favored Patients Act H.R. 7391, the Community Health Center Drug Pricing Protection Act H.R. 7953: FAIR ACT H.R. 8269: CLEAR LABELS Act Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future (SUSTAIN) 340B Act (draft) 340B Drug Pricing Integrity and Affordability for Patients Act (draft) SECURE Act of 2026 (draft) Biopharmaceutical innovation policy issues User fee issues Vaccine policy issues Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues IRA price negotiation expansion policy issues Pharmacy Benefit Manager reform and policy issues Drug cost and pricing policy issues Most Favored Nation (MFN) policy issues Drug importation policy issues FDA policy issues Competition policy issues Orphan Drug Act policy issues Antimicrobial resistance policy issues Compounding policy issues Supply chain policy issues Clinical trial policy issues 340B drug discount program rebate and policy issues 340B rebate pilot program Patient assistance program policy issues Biosimilar approval and reimbursement policy issues Drug shortages policy issues Artificial intelligence policy issues Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Executive Order: Lowering Drug Prices by Once Again Putting Americans First S. 891, Bipartisan Health Care Act (including section 227 - Modernizing and Ensuring PBM Accountability) S.4784, An original bill to authorize appropriations for fiscal year 2027 for military activities of the Department of Defense, for military construction, and for defense activities of the Department of Energy, to prescribe military personnel strengths for such fiscal year, and for other purposes, Provisions related to the pharmaceutical industry. Smucker's VICP bill Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future (SUSTAIN) 340B Act (draft) Vaccine policy issues
2026 · first_quarter · Health Issues
issues pertaining to 340B rebate pilot program, support of Community Health Center Drug Pricing Protection Act (HR 7391)
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Health Issues
HCR: NACHC lobbies for Teaching Health Centers; Nurse Corps; National Health Service Corps; 340B Drug Discount Program; Community Health Center Program Funding; Behavioral Health; Telehealth and Nutrition policies. This includes the HEALTH Act (H.R. 5496), Telehealth Modernization Act (H.R. 5081 / S. 2709), CONNECT for Health Act of 2025 (H.R. 4206 / S.1261) and the Community Health Center Drug Pricing Protection Act (H.R.7391).
Client expense: $196,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE, White House Office
2026 · first_quarter · Health Issues
H.R. 7148, the Consolidated Appropriations Act, 2026 Issues related to the Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations for FY 2027, especially funding for the Community Health Center Program and the National Health Service Corps H.R.1 One Big Beautiful Bill Act implementation, specifically state-based operations to implement the Rural Health Transformation Program and Medicaid changes, like community engagement requirements and new limits to funding mechanisms 340B Drug Pricing Program legislation, including the SUSTAIN Act, 340B Patients Act (HR 4581), the Community Health Center Drug Pricing Protection Act (HR 7391), and proposed 340C legislation Comments and legislative efforts to block 340B Rebate Model efforts and manufacturers efforts to compel claims data, including meetings with CMS and OMB Statement submitted to the House Committee on Budgets hearing, Reverse the Curse: Skyrocketing Health Care Costs and Americas Fiscal Future RFI Response to Congressional Doctors Caucuses on Proposed Payment Reforms Submitted comments to the Department of Education Re: Reimagining and Improving Student Education Proposed Rule, 34 CFR Parts 674, 682, and 685 [Docket ID ED-2025-OPE-0944] RIN 1840-AD98 Issues and legislation related to the primary care workforce, including advancing the Developing the Community Health Workforce Act, the Health Workforce Innovation Act (HR935), H-1Bs for Physicians and the Healthcare Workforce Act (HR7961), the Community TEAMS Act of 2025 (HR3885), funding for Title 7 & Title 8 workforce programs and activities related to a new workforce coalition, The Alliance to Strengthen Americas Health Workforce for the Underserved Issues related to CMMI models and health center participation in value-based care payment arrangements, including MAHA Elevate, ACCESS, and LEAD Issues related to the Health Center Community Transformation Hub Act (Has not been reintroduced in 119th Congress) Issues related to the Trump Administrations stance on community health centers and primary care workforce funding, including the Make America Healthy Again agenda (nutrition and chronic disease management)
2026 · first_quarter · Health Issues
- H.R. 1539, Medical Device Electronic Labeling Act, regarding all provisions - H.R. 929/S. 266, the Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, regarding all provisions - H.R. 946 ORPHAN Cures Act, regarding all provisions - S.864, HELP Copays Act, regarding all provisions - H.R. 2214, Delinking Revenue from Unfair Gouging (DRUG) Act, regarding all provisions - H.R. 1492/S. 832, Ensuring Pathways to Innovative Cures (EPIC) Act - S. 1954/ H.R. 5526 Biosimilar Red Tape Elimination Act, regarding all provisions - H.R.2527, Early Detection of Vision Impairments for Children Act of 2025, regarding all provisions - PL117-169 The Inflation Reduction Act, regarding all provisions related to drug pricing and implementation - H.R.5343/S. 1717, the Ensuring Patient Access to Critical Breakthrough Products Act of 2025, regarding all provisions - H.R.4282, Contact Lens Prescription Verification Modernization Act, regarding all provisions - H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act, regarding all provisions - S.1399 / H.R. 6197, the Health Tech Investment Act, regarding all provisions - H.R. 3521, the Clinical Trial Modernization Act, regarding all provisions - H.R. 3006 / S.1776, the Medicare Beneficiary Co-Pay Fairness Act, regarding all provisions - H.R. 3514, the Improving Seniors Timely Access to Care Act of 2025, regarding all provisions - H.R. 6549, the VA Contracting and Procurement Act, regarding all provisions - H.R. 5509 / S. 2903, Safe Step Act, regarding all provisions - H.R. 5256, 340B ACCESS Act, regarding all provisions - H.R. 7391, Community Health Center Drug Pricing Protection Act, regarding all provisions Issues related to - direct to consumer advertising - clinical trial modernization - biosimilars - cardiovascular health - 340B and 340B Rebate Pilot - Heart Recovery Awareness Day & H.Res. 1301, designating February 20th Heart Recovery Awareness Day - obesity treatments - MFN - Foreign Reference Pricing - CMS Outpatient Prospective Payment System rule - peripheral artery disease (PAD) - PBM and Insurer Reforms
2026 · first_quarter · Health Issues
H.R.1492, Ensuring Pathways to Innovation Cures (EPIC) Act Implementation of Inflation Reduction Act of 2022 ORPHAN Cures Act MINI Act H.R.4299, the Protecting Patient Access to Cancer and Complex Therapies Act of 2025 H.R.7391, CHC Drug Pricing Protection Act H.R.5509, Safe Step Act Issues related to biosimilars reimbursement issues Clinical Trial Modernization Act
Client expense: $1,320,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Health Issues
HCR: NACHC lobbies for Teaching Health Centers; Nurse Corps; National Health Service Corps; 340B Drug Discount Program; Community Health Center Program Funding; Behavioral Health; Telehealth and Nutrition policies. This includes the HEALTH Act (H.R. 5496), Telehealth Modernization Act (H.R. 5081 / S. 2709), CONNECT for Health Act of 2025 (H.R. 4206 / S.1261) and the Community Health Center Drug Pricing Protection Act (H.R.7391).
Client expense: $191,100 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE, White House Office
2026 · first_quarter · Health Issues
HCR: NACHC lobbies for Teaching Health Centers; Nurse Corps; National Health Service Corps; 340B Drug Discount Program; Community Health Center Program Funding; Behavioral Health; Telehealth and Nutrition policies. This includes the HEALTH Act (H.R. 5496), Telehealth Modernization Act (H.R. 5081 / S. 2709), CONNECT for Health Act of 2025 (H.R. 4206 / S.1261) and the Community Health Center Drug Pricing Protection Act (H.R.7391).
Client expense: $189,300 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE, White House Office
2026 · first_quarter · Pharmacy
340B Drug Rebate Proposals, Contract Pharmacy - 340B PATIENTS Act reintroduction in the House and Senate; Budget reconciliation, H Con Res 14, House & Senate Budget Resolution; H.R.44: To amend title III of the Public Health Service Act to include rural emergency hospitals in the definition of a covered entity for purposes of the 340B drug discount program; S. 523: A bill to amend title XIX of the Social Security Act to prohibit Federal Medicaid funding for the administrative costs of providing health benefits to individuals who are unauthorized immigrants; H.R.1195: To amend title XIX of the Social Security Act to prohibit Federal Medicaid funding for the administrative costs of providing health benefits to individuals who are unauthorized immigrants; PBM, Reintroduction of 340B PROTECT Act in the House; FY 2026 Labor HHS Appropriations Act, House & Senate; Draft Senate 340B reform legislation - 340B SUSTAIN Act; HR 2197, No 340B Savings for Transgender Care Act; Implementation of the Inflation Reduction Act; S.891 - Bipartisan Health Care Act, HR1, the One BIg Beautiful Bill, Budget Reconciliation, H.R. 5256, 340B ACCESS Act; H.R. 7391 - Community Health Center Drug Pricing Protection Act
Client expense: $337,176 · Firm income: Not reported
| Republican |
| MI |
| Carol D. Miller | Republican | WV |
| Celeste Maloy | Republican | UT |
| Cleo Fields | Democratic | LA |
| David J. Taylor | Republican | OH |
| David Rouzer | Republican | NC |
| Derek Schmidt | Republican | KS |
| Derrick Van Orden | Republican | WI |
| Dina Titus | Democratic | NV |
| Donald G. Davis | Democratic | NC |
| Ed Case | Democratic | HI |
| Eleanor Holmes Norton | Democratic | DC |
| Emanuel Cleaver | Democratic | MO |
| Eugene Simon Vindman | Democratic | VA |
| Frank D. Lucas | Republican | OK |
| Frank J. Mrvan | Democratic | IN |
| Gabe Vasquez | Democratic | NM |
| Gilbert Ray Cisneros, Jr. | Democratic | CA |
| Greg Casar | Democratic | TX |
| Harold Rogers | Republican | KY |
| Jahana Hayes | Democratic | CT |
| Jake Auchincloss | Democratic | MA |
| Jason Crow | Democratic | CO |
| Jeff Crank | Republican | CO |
| Jill N. Tokuda | Democratic | HI |
| Joe Neguse | Democratic | CO |
| Jonathan L. Jackson | Democratic | IL |
| Josh Riley | Democratic | NY |
| Lloyd Smucker | Republican | PA |
| Lois Frankel | Democratic | FL |
| Madeleine Dean | Democratic | PA |
| Marie Gluesenkamp Perez | Democratic | WA |
| Mark E. Amodei | Republican | NV |
| Monica De La Cruz | Republican | TX |
| Nicholas J. Begich III | Republican | AK |
| Nikki Budzinski | Democratic | IL |
| Paul Tonko | Democratic | NY |
| Raja Krishnamoorthi | Democratic | IL |
| Rashida Tlaib | Democratic | MI |
| Raul Ruiz | Democratic | CA |
| Rick Larsen | Democratic | WA |
| Ritchie Torres | Democratic | NY |
| Robert P. Bresnahan, Jr. | Republican | PA |
| Sanford D. Bishop, Jr. | Democratic | GA |
| Sarah McBride | Democratic | DE |
| Seth Moulton | Democratic | MA |
| Sharice Davids | Democratic | KS |
| Shri Thanedar | Democratic | MI |
| Stephen F. Lynch | Democratic | MA |
| Steve Cohen | Democratic | TN |
| Susie Lee | Democratic | NV |
| Tom Cole | Republican | OK |
| Tracey Mann | Republican | KS |
| William R. Keating | Democratic | MA |
| Yassamin Ansari | Democratic | AZ |
Client expense: $85,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE, White House Office
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $1,440,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $890,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
Client expense: $85,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE, White House Office
Client expense: $3,510,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE